First Time Loading...

Amedisys Inc
NASDAQ:AMED

Watchlist Manager
Amedisys Inc Logo
Amedisys Inc
NASDAQ:AMED
Watchlist
Price: 91.84 USD 0.05% Market Closed
Updated: Apr 30, 2024
Section:
 

Relative Value

The Relative Value of one AMED stock under the Base Case scenario is 131.32 USD. Compared to the current market price of 91.84 USD, Amedisys Inc is Undervalued by 30%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

AMED Relative Value
Base Case
131.32 USD
Undervaluation 30%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

1.3
P/S
P/S
Price to Sales
1.3
vs History
84
vs Industry
60
Median 3Y
1.4
Median 5Y
2.2
Industry
2.4
Forward
1.3
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
0
Median 3Y
25.6
Median 5Y
31.9
Industry
23.2
Forward
19.7
More Details
21.9
P/OCF
P/OCF
Price to OCF
21.9
vs History
73
vs Industry
19
Median 3Y
23.7
Median 5Y
25.3
Industry
15.5
More Details
52.9
P/FCFE
P/FCFE
Price to FCFE
52.9
vs History
25
vs Industry
11
Median 3Y
47.9
Median 5Y
23.8
Industry
23.5
More Details
2.8
P/B
P/B
Price to Book Value
2.8
vs History
90
vs Industry
32
Median 3Y
3.1
Median 5Y
6.4
Industry
2.2
More Details
1.4
EV/S
EV/S
Enterprise Value to Sales
1.4
vs History
92
vs Industry
59
Median 3Y
1.6
Median 5Y
2.4
Industry
2.5
Forward
1.4
More Details
3.3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3.3
vs History
92
vs Industry
58
Median 3Y
3.6
Median 5Y
5.6
Industry
5.2
More Details
14.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
14.9
vs History
85
vs Industry
24
Median 3Y
16.2
Median 5Y
20.6
Industry
12.5
Forward
12.6
More Details
16.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
16.8
vs History
85
vs Industry
28
Median 3Y
18.3
Median 5Y
23
Industry
17.2
Forward
14.3
More Details
23.6
EV/OCF
EV/OCF
Enterprise Value to OCF
23.6
vs History
76
vs Industry
18
Median 3Y
26.4
Median 5Y
26.5
Industry
15.1
More Details
26
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
26
vs History
68
vs Industry
20
Median 3Y
27
Median 5Y
27.3
Industry
19.7
More Details
1.7
EV/IC
EV/IC
Enterprise Value to IC
1.7
vs History
92
vs Industry
43
Median 3Y
1.9
Median 5Y
3.4
Industry
2
More Details

Multiples Across Competitors

AMED Competitors Multiples
Amedisys Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Amedisys Inc
NASDAQ:AMED
3B USD 1.3 -307.8 14.9 16.8
US
Cigna Corp
NYSE:CI
104.3B USD 0.5 20.2 10.3 13.8
US
Cigna Group
XMUN:CGN
96.6B EUR 0.5 20.1 10.3 13.7
US
CVS Health Corp
NYSE:CVS
86.9B USD 0.2 10.4 8.9 8.9
DE
Fresenius Medical Care AG
XMUN:FME
22B EUR 1.1 44.1 10.3 24.5
US
Laboratory Corporation of America Holdings
NYSE:LH
17.2B USD 1.4 39.7 12.1 18.2
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.6B EUR 0.7 -26.2 10 22.4
US
Quest Diagnostics Inc
NYSE:DGX
15.5B USD 1.7 18.4 10.9 14.7
US
DaVita Inc
NYSE:DVA
12.3B USD 1 17.7 8.6 12.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.3B EUR 0.6 22.7 6.8 16.1
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
AMED intrinsic value, competitors valuation, and company profile.
DCF Valuation
AMED stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AMED stock valuation using valuation multiples.
Wall Street Estimates
AMED price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AMED stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 132,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.